Mesangial proliferative glomerulonephritis overview

Mesangial proliferative glomerulonephritis Microchapters
Home
Overview
Pathophysiology
Causes
Differentiating Mesangial proliferative glomerulonephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mesangial proliferative glomerulonephritis overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mesangial proliferative glomerulonephritis overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mesangial proliferative glomerulonephritis overview
CDC on Mesangial proliferative glomerulonephritis overview
Mesangial proliferative glomerulonephritis overview in the news
Blogs on Mesangial proliferative glomerulonephritis overview
Directions to Hospitals Treating Mesangial proliferative glomerulonephritis
Risk calculators and risk factors for Mesangial proliferative glomerulonephritis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Mesangial proliferative glomerulonephritis is a form of glomerulonephritis associated primarily with the mesangium.

There is some evidence that interleukin-10 may inhibit it in an animal model.

It is classified as type II lupus nephritis by the WHO.